Koyfin Home > Directory > Health Care > Biogen Inc > Cash from Financing Activities

Biogen Inc Cash from Financing Activities Chart (BIIB)

Biogen Inc annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Biogen Inc Cash from Financing Activities for the quarter ending September 09, 2020 was $-1,313m a -61.20% increase of 804m year over year
  • Biogen Inc Cash from Financing Activities for the last 12 months ending September 09, 2020 was $-6,988m a 16.14% decrease of -1,128m year over year
  • Biogen Inc Annual Cash from Financing Activities for 2019 was $-5,860m a 23.69% decrease of -1,388m from 2018
  • Biogen Inc Annual Cash from Financing Activities for 2018 was $-4,472m a 46.78% decrease of -2,092m from 2017
  • Biogen Inc Annual Cash from Financing Activities for 2017 was $-2,380m a 55.77% decrease of -1,327m from 2016
Other Cash Flow Metrics:
  • Biogen Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $1,736m a 12.54% increase of 218m year over year
  • Biogen Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $1,098m a 0.14% increase of 2m year over year
  • Biogen Inc Total Revenue for the quarter ending December 12, 2018 was $3,526m a 11.21% increase of 395m year over year
View Chart On Koyfin

Quarterly BIIB Cash from Financing Activities Data

09/2020$-1,313m
06/2020$-1,313m
03/2020$-2,245m
12/2019$-2,116m
09/2019$-689m
06/2019$-2,376m
03/2019$-679m
12/2018$-1,437m
09/2018$25m
06/2018$-2,792m

Annual BIIB Cash from Financing Activities Data

2019$-5,860m
2018$-4,472m
2017$-2,380m
2016$-1,053m
2015$783m
2014$-756m
2013$-717m
2012$-877m
2011$-320m
2010$-1,785m